Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-06-03

Clinical Trial Update: A Study of LY2922470 in Healthy Participants and Participants With Diabetes [Phase 1]

View source ↗

Summary

Phase 1 study of LY2922470 in healthy participants and individuals with Type 2 diabetes has completed; results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LY2922470

Snippet

Sponsor: Eli Lilly and Company | Conditions: Diabetes Mellitus, Type 2 | Phase 1 | Status: COMPLETED | Results posted: 2019-06-03